Skip to main content

Epogen Sales Data

Rank 20 Current sales rank, all
U.S. Pharmaceuticals.

Last updated: February 2014 (updated quarterly).
The following data shows Epogen U.S. retail sales in Q4 2013 compared to previous quarters.

Date Range Sales Rank Sales ($000) Units (000)
Q4 2013 20 1.54% 1.12%
Q3 2013 20 (1) 3.80% 2.30%
Q2 2013 21 (2) 9.40% 3.39%
Q1 2013 23 (3) -2.08% -2.64%
Q4 2012 20 -2.27% -0.16%
Q3 2012 20 (2) -5.18% -3.04%
Q2 2012 22 (5) 13.33% 12.79%
Q1 2012 27 (7) -24.54% -17.04%
Q4 2011 20 (2) 4.67% 3.40%
Q3 2011 22 (2) -13.96% -18.41%
Q2 2011 20 (1) 3.32% 4.48%
Q1 2011 19 n/a n/a

* Units refer to the number of packages sold.

Source: IMS Health (Midas). Please review our terms of use and attribution guidelines. Copyright - All rights reserved. Unauthorized use and/or duplication of this material without express written permission is strictly prohibited.